however, systemic hypotension, bradycardia, or dizziness require prompt cessation and clinical review
On the innovation front, the FDA recently approved Belzutifan, an HIF-2 alpha inhibitor, as the first oral therapy for locally advanced or metastatic pheochromocytoma or paraganglioma, opening a new era for unresectable cases [FDA]
Because the specific handling requirements belong on the label you were dispensed, follow that label and ask the pharmacy if anything about storage is unclear
In this article, we will go through the guideline-directed recommendations about what the next steps are after metformin
Copper-regulated trafficking of the Menkes disease copper ATPase is associated with formation of a phosphorylated catalytic intermediate
Retrieved January 10, 2021